VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
134 hedge funds and large institutions have $847M invested in Verve Therapeutics in 2023 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 58 increasing their positions, 24 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.31% more ownership
Funds ownership: 99.94% → 100.25% (+0.31%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
27% less capital invested
Capital invested by funds: $1.16B → $847M (-$313M)
Holders
134
Holding in Top 10
3
Calls
$7M
Puts
$4.99M
Top Buyers
| 1 | +$9.84M | |
| 2 | +$8.84M | |
| 3 | +$7.88M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.04M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$2.85M |
Top Sellers
| 1 | -$9.38M | |
| 2 | -$7.87M | |
| 3 | -$6.08M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$3.49M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$3.34M |